Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML
Clinical trial NCT02926586 · COMPLETED
Trial details
- NCT number
- NCT02926586
- Sponsor
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2020-08-16
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.